Tevogen Bio Ownership | Who Owns Tevogen Bio?
Tevogen Bio Ownership Summary
Tevogen Bio is owned by 0.03% institutional investors, 80.65% insiders, and 19.31% retail investors. Creative planning is the largest institutional shareholder, holding 0.03% of TVGN shares.
TVGN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Tevogen Bio | 0.03% | 80.65% | 19.31% |
Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Creative planning | 50.00K | 0.03% | $54.00K |
Millennium management | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Creative planning | 50.00K | 0.00% | $54.00K |
Millennium management | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Creative planning | 50.00K | 0.00% | - |
Millennium management | - | - | -14.22K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Millennium management | - | - | -14.22K |
Creative planning | 50.00K | 0.00% | - |
Sold Out
Holder | Change |
---|---|
Millennium management | -14.22K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 1 | -97.50% | 50,000 | -97.83% | - | 1.86% | - | -100.00% | - | -100.00% |
Dec 31, 2024 | 42 | 27.27% | 2,408,376 | -57.37% | 1 | 12.84% | 32 | 33.33% | 6 | - |
Sep 30, 2024 | 33 | 22.22% | 5,649,636 | -0.60% | 3 | 24.43% | 24 | -4.00% | 6 | 500.00% |
Jun 30, 2024 | 27 | 440.00% | 5,683,714 | -16.16% | 3 | 15.13% | 25 | 400.00% | 1 | - |
Mar 31, 2024 | 5 | - | 6,779,132 | - | 4 | - | 5 | - | - | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jun 09, 2025 | Saadi Ryan H. | Chief Executive Officer | Sell | $1.77M |
Mar 12, 2025 | Flomenberg Neal | See Remarks | Sell | $253.94K |
Mar 11, 2025 | Flomenberg Neal | See Remarks | Sell | $73.76K |
Mar 07, 2025 | Flomenberg Neal | See Remarks | Sell | $81.25K |
Mar 10, 2025 | Flomenberg Neal | See Remarks | Sell | $76.72K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | 1 |
2025 Q1 | - | 7 |
2024 Q4 | - | 1 |
2024 Q2 | 2 | - |
2024 Q1 | - | - |
TVGN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools